from the world's big
2018 Nobel Prize awarded to cancer immunotherapy pioneers
In the 1990s, the two scientists made key discoveries that led to the development of promising new cancer-fighting immunotherapy drugs.
- The two researchers, from the U.S. and Japan, made key discoveries about the immune system's response to cancer.
- Their work showed how to block cancer cells from crippling white blood cells.
- Still in its early stages, immunotherapy is a promising field in cancer research.
James Allison and Tasuku Honjo have won the 2018 Nobel Prize in Physiology or Medicine for their innovative work in developing immunotherapy treatments to fight cancer.
James P. Allison, 70, is the chair of the department of immunology at MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo, 76, is a professor at the Kyoto University Institute for Advanced Study in Japan. In the 1990s, the two scientists made separate breakthrough discoveries about the immune system that led to the development of immunotherapy drugs. They will share the $1 million prize.
Allison was in New York for an immunology conference when his son called early one morning to tell him the good news. An hour later, Allison and his colleagues were celebrating in a hotel room over champagne.
"It still hasn't completely dawned on me," said Allison, at a press conference. "I was a basic scientist. To have my work really impact people is one of the best things I could think about. It's everybody's dream."
Honjo also spoke about the personal satisfaction he gets from seeing his work benefit patients.
"When I'm thanked by patients who recover, I truly feel the significance of our research," Honjo said during a news conference at the Japanese university, according to Japanese news reports. He added: "I'd like to continue researching cancer for a while so that this immunotherapy will help save more cancer patients than ever before."
How immunotherapy works
Immunotherapy effectively removes the 'brakes' on the body's immune system, allowing for a certain type of white blood cell, called T-cells, to hunt down and kill cancer cells. Without immunotherapy treatment, cancer cells can deactivate T-cells by taking advantage of a switch on the cells, called an immune checkpoint. This shuts down the body's immune response and allows the cancer to spread unchecked.
Image: Nobel committee
Immunotherapies keep cancer-fighting T-cells active by blocking the immune checkpoints. In the 1990s, Allison and Honjo made key discoveries about immune checkpoints that later led to the development of immunotherapies that have proven successful in humans; Allison identified a checkpoint called CTLA-4, Honjo found another called PD-1.
The development and testing of immunotherapy drugs is still in early stages. However, immunotherapy has shown promising signs in recent years in combating several types of cancer, particularly lung cancer, even reversing the disease completely in some patients.
Photo: JONATHAN NACKSTRAND/AFP/Getty Images
Many scientists have helped develop the field of immunotherapy, but the work of Allison and Honjo helped build a foundation from which it could grow.
"I think they really deserve it," Jerome Galon, an immunologist at the Paris-based national biomedical research agency INSERM, told Nature. "You can always multiply and have many other people, but these are the obvious two first choices."
Their work "brought immunotherapy out from decades of skepticism" and has led to treatments that have improved an "untold number of people's health," Dr. Jedd Wolchok, a cancer specialist at Memorial Sloan Kettering Cancer Center in New York, told The New York Times.
The Nobel committee wrote that scientists have been searching for ways to bolster the immune system against cancer for more than a century, but the progress was "modest" until the revolutionary work of Allison and Honjo.
"Allison's and Honjo's discoveries have added a new pillar in cancer therapy. It represents a completely new principle, because unlike previous strategies, it is not based on targeting the cancer cells, but rather the brakes — the checkpoints — of the host immune system," Klas Kärre, a member of the Nobel Committee and an immunologist at the Karolinska Institute in Stockholm, said in a statement. "The seminal discoveries by the two laureates constitutes a paradigmatic shift and a landmark in the fight against cancer."
Sallie Krawcheck and Bob Kulhan will be talking money, jobs, and how the pandemic will disproportionally affect women's finances.
A recent study on monkeys found that stimulating a certain part of the forebrain wakes monkeys from anesthesia.
- Scientists electrically stimulated the brains of macaque monkeys in an effort to determine which areas are responsible for driving consciousness.
- The monkeys were anesthetized, and the goal was to see whether activating certain parts of the brain would wake up the animals.
- The forebrain's central lateral thalamus seems to be one of the "minimum mechanisms" necessary for consciousness.
Pixabay<p>When the team electrically stimulated a part of the brain called the central lateral thalamus, located in the forebrain, the monkeys woke up: they opened their eyes, blinked, reached out, made facial expressions and showed altered vital signs. </p><p>"We found that when we stimulated this tiny little brain area, we could wake the animals up and reinstate all the neural activity that you'd normally see in the cortex during wakefulness," Saalmann told Cell Press. "They acted just as they would if they were awake. When we switched off the stimulation, the animals went straight back to being unconscious."</p><p>This area of the brain may function as an "engine for consciousness," Redinbaugh told Inverse. Although past studies have shown that electrical stimulation can arouse the brains of humans and animals, the new findings are unique because they reveal which specific neural interactions appear to be minimally necessary for consciousness.</p><p>"Science doesn't often leave opportunity for exhilaration, but that's what that moment was like for those of us who were in the room," Redinbaugh told <a href="https://www.inverse.com/science/first-squid-mri-study-brain-complexity-similar-dogs" target="_blank"><em>Inverse</em></a><em>.</em></p>
Future applications<p>The team said the findings could have many applications down the road, but more research is needed.</p><p>"The overriding motivation of this research is to help people with disorders of consciousness to live better lives," Redinbaugh told Cell Press. "We have to start by understanding the minimum mechanism that is necessary or sufficient for consciousness, so that the correct part of the brain can be targeted clinically."</p><p>"It's possible we may be able to use these kinds of deep-brain stimulating electrodes to bring people out of comas. Our findings may also be useful for developing new ways to monitor patients under clinical anesthesia, to make sure they are safely unconscious."</p>
The coronavirus pandemic has brought out the perception of selfishness among many.
- Selfish behavior has been analyzed by philosophers and psychologists for centuries.
- New research shows people may be wired for altruistic behavior and get more benefits from it.
- Crisis times tend to increase self-centered acts.
Paul Krugman on the Virtues of Selfishness<div class="rm-shortcode" data-media_id="7ZtAkm6C" data-player_id="FvQKszTI" data-rm-shortcode-id="828936bf6953080e9018307354c0c02b"> <div id="botr_7ZtAkm6C_FvQKszTI_div" class="jwplayer-media" data-jwplayer-video-src="https://content.jwplatform.com/players/7ZtAkm6C-FvQKszTI.js"> <img src="https://cdn.jwplayer.com/thumbs/7ZtAkm6C-1920.jpg" class="jwplayer-media-preview" /> </div> <script src="https://content.jwplatform.com/players/7ZtAkm6C-FvQKszTI.js"></script> </div> The Nobel Prize-winning economist on the virtues of selfishness.
Evolution Is Moving Us Away from Selfishness. But Where Is It Taking ...<div class="rm-shortcode" data-media_id="cyeqmYCb" data-player_id="FvQKszTI" data-rm-shortcode-id="6c5efecb56456e9acc25cf36935b1826"> <div id="botr_cyeqmYCb_FvQKszTI_div" class="jwplayer-media" data-jwplayer-video-src="https://content.jwplatform.com/players/cyeqmYCb-FvQKszTI.js"> <img src="https://cdn.jwplayer.com/thumbs/cyeqmYCb-1920.jpg" class="jwplayer-media-preview" /> </div> <script src="https://content.jwplatform.com/players/cyeqmYCb-FvQKszTI.js"></script> </div>
Exploring Morality and Selfishness in Modern Times<div class="rm-shortcode" data-media_id="02eX1Cag" data-player_id="FvQKszTI" data-rm-shortcode-id="45cc6180db791f32683988fb52faff26"> <div id="botr_02eX1Cag_FvQKszTI_div" class="jwplayer-media" data-jwplayer-video-src="https://content.jwplatform.com/players/02eX1Cag-FvQKszTI.js"> <img src="https://cdn.jwplayer.com/thumbs/02eX1Cag-1920.jpg" class="jwplayer-media-preview" /> </div> <script src="https://content.jwplatform.com/players/02eX1Cag-FvQKszTI.js"></script> </div> Philosopher Peter Singer discusses the state of global ethics.
Parenting could be a distraction from what mattered most to him: his writing.
Ernest Hemingway was affectionately called “Papa," but what kind of dad was he?